AIMS: The nuclear proliferation marker Ki67 assayed by immunohistochemistry has multiple potential uses in breast cancer, but an unacceptable level of interlaboratory variability has hampered its clinical utility. The International Ki67 in Breast Cancer Working Group has undertaken a systematic prog...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!